AARDVARK THERAPEUTICS INC (AARD) Stock Income Statement
USA - NASDAQ:AARD - US0029421007 - Common Stock
10.7 USD
-0.15 (-1.38%)
10.7 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 40.86M | 22.79M | 7.42M | 10.36M | |||
| Research and Development | 33.03M | 17.36M | 4.48M | 7.17M | |||
| Selling, General, and Administrative Expenses | 7.83M | 5.42M | 2.94M | 3.19M | |||
| Operating Income | -40.86M | -22.79M | -7.42M | -10.36M | |||
| Interest Income/Expense | 4.22M | 2.20M | 207.00K | -2.20M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -1.00M | |||
| Income Before Taxes | -36.64M | -20.59M | -7.21M | -13.56M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -36.64M | -20.59M | -7.21M | -13.56M | |||
| EBITDA | -40.88M | -22.77M | -7.32M | -10.25M | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -1.97 | -0.96 | -0.34 | -0.63 | |||
| Statistics | |||||||
All data in USD